aTyr Pharma, Inc.
COMPOSITIONS AND METHODS COMPRISING ANTI-NRP2 ANTIBODIES

Last updated:

Abstract:

Provided are antibodies and antigen-binding fragments thereof that specifically bind to human neuropilin-2 (NRP2) polypeptides, including those that modulate binding interactions between human NRP2 and at least one NRP2 ligand, for example, human histidyl-tRNA synthetase (HRS), and which thereby modulate subsequent NRP2-mediated downstream signaling events, including related therapeutic compositions and methods for modulating NRP2 activity and treating diseases such as NRP2-associated diseases

Status:
Application
Type:

Utility

Filling date:

5 Apr 2019

Issue date:

10 Oct 2019